Campbell & CO Investment Adviser LLC Novo Nordisk A S Transaction History

Campbell & CO Investment Adviser LLC

  • $1.53 Billion
  • Q2 2025

A detailed history of Campbell & CO Investment Adviser LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 9,184 shares of NVO stock, worth $457,179. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,184
Previous 44,969 79.58%
Holding current value
$457,179
Previous $3.12 Million 79.72%
% of portfolio
0.04%
Previous 0.25%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$58.08 - $81.05 $2.08 Million - $2.9 Million
-35,785 Reduced 79.58%
9,184 $633,000
Q1 2025

May 14, 2025
BUY
$69.3 - $90.95 $2.77 Million - $3.63 Million
39,923 Added 791.18%
44,969 $3.12 Million
Q4 2024

Feb 10, 2025
SELL
$85.0 - $120.04 $478,720 - $676,065
-5,632 Reduced 52.74%
5,046 $434,000
Q3 2024

Nov 12, 2024
SELL
$119.07 - $145.42 $681,794 - $832,674
-5,726 Reduced 34.91%
10,678 $1.27 Million
Q2 2024

Aug 13, 2024
SELL
$122.71 - $146.91 $1,717 - $2,056
-14 Reduced 0.09%
16,404 $2.34 Million
Q1 2024

May 10, 2024
BUY
$102.11 - $135.92 $1.68 Million - $2.23 Million
16,418 New
16,418 $2.11 Million
Q3 2023

Nov 08, 2023
SELL
$90.94 - $199.54 $123,951 - $271,973
-1,363 Reduced 20.71%
5,219 $474,000
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $590,696 - $653,825
-3,787 Reduced 36.52%
6,582 $1.07 Million
Q1 2023

May 11, 2023
BUY
$132.34 - $159.14 $1.37 Million - $1.65 Million
10,369 New
10,369 $1.65 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $41,256 - $50,630
-433 Reduced 11.44%
3,352 $334,000
Q2 2022

Aug 09, 2022
BUY
$103.24 - $121.81 $390,763 - $461,050
3,785 New
3,785 $422,000
Q1 2021

May 14, 2021
SELL
$67.06 - $75.82 $192,261 - $217,375
-2,867 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$63.89 - $73.8 $183,172 - $211,584
2,867 New
2,867 $200,000
Q2 2019

Jul 10, 2019
SELL
$46.79 - $52.47 $227,492 - $255,109
-4,862 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$46.36 - $52.63 $17,014 - $19,315
367 Added 8.16%
4,862 $254,000
Q4 2018

Feb 08, 2019
SELL
$41.54 - $47.25 $120,922 - $137,544
-2,911 Reduced 39.31%
4,495 $229,000
Q3 2018

Nov 08, 2018
BUY
$46.76 - $51.24 $346,304 - $379,483
7,406 New
7,406 $349,000

Others Institutions Holding NVO

# of Institutions
1,748
Shares Held
332M
Call Options Held
10.5M
Put Options Held
16.2M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $112B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email